UCLA Scientists Receive $4.7 Million in CIRM Grants to Advance Novel Stem Cell-based Treatments for Female-Specific Diseases and Leukemia in Down Syndrome
September 30, 2025
September 30, 2025
LOS ANGELES, California, Sept. 30 -- The UCLA Health issued the following news release:
* * *
UCLA scientists receive $4.7 million in CIRM grants to advance novel stem cell-based treatments for female-specific diseases and leukemia in Down syndrome
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received $4.7 million in grants from the California Institute for Regenerative Medicine, the state' . . .
* * *
UCLA scientists receive $4.7 million in CIRM grants to advance novel stem cell-based treatments for female-specific diseases and leukemia in Down syndrome
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received $4.7 million in grants from the California Institute for Regenerative Medicine, the state' . . .